Modular Medical (MODD) 8-K 仅公告2027财年股东大会日期及股东提案截止日，属例行行政备案

----- ea0304617-8k_modular.htm -----
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event Reported):
September 3, 2026
MODULAR MEDICAL, INC.
(Exact Name of Registrant as Specified in Charter)
001-41277
(Commission File Number)
Nevada
87-0620495
(State or Other Jurisdiction
of Incorporation)
(I.R.S. Employer
Identification Number)
10740 Thornmint Road
San Diego
,
California
92127
(Address of principal executive offices, with zip
code)
(
858
)
800-3500
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock
MODD
The
Nasdaq
Stock Market LLC
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR§230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.08 Shareholder Director Nominations.
On September 3, 2026, the board of directors of
Modular Medical, Inc. (the “Company”) set October 23, 2026 as the date of the Company’s fiscal 2027 Annual Meeting of
Shareholders (the “2027 Annual Meeting”). The 2027 Annual Meeting will be a virtual meeting. Shareholders of record at the
close of business on September 10, 2026 will be entitled to notice of and to vote at the 2027 Annual Meeting. Because the date of the
2027 Annual Meeting is more than 30 days before the anniversary date of the fiscal 2026 Annual Meeting of Shareholders, the Company is
providing the due date for submission of any qualified shareholder proposal or qualified shareholder nominations.
Shareholders of the Company who wish to have a
proposal considered for inclusion in the Company’s proxy materials for the 2027 Annual Meeting pursuant to Rule 14a-8 under the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), must ensure that such proposal is received by the Company’s
Secretary at its principal executive offices at the address set forth above on or prior to 5:00 p.m. (Eastern time) on September 13, 2026,
which the Company has determined to be a reasonable time before it expects to begin to print and send its proxy materials. Any such proposal
must also meet the requirements set forth in the rules and regulations of the Securities and Exchange Commission in order to be eligible
for inclusion in the proxy materials for the 2027 Annual Meeting.
In addition, in accordance with the requirements
contained in the Company’s bylaws, shareholders of the Company who wish to bring business before the 2027 Annual Meeting outside
of Rule 14a-8 of the Exchange Act or to nominate a person for election as a director must ensure that written notice of such proposal
(including all information specified in the Company’s bylaws) is received by the Company’s Secretary at the Company’s
principal executive offices at the address set forth above no later than 5:00 p.m. (Eastern time) on September 13, 2026. Any such proposal
must meet the requirements set forth in the Company’s bylaws to be brought before the 2026 Annual Meeting.
In addition, to comply with the universal proxy
rules, shareholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must provide
notice that sets forth the information required by Rule 14a-19 under the Exchange Act by 5:00 p.m. (Eastern time) on September 13, 2026,
which is the tenth calendar day following the date of this Current Report on Form 8-K publicly announcing the date of the 2027 Annual
Meeting.
1
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MODULAR MEDICAL, INC.
Date: September 3, 2026
By:
/s/ James Besser
James Besser
Chief Executive Officer
2